Daniel Morgenstern

32PUBLICATIONS
189CO-AUTHORS
Predictive and prognostic markersNeurology and neuromuscular diseasesCancer geneticsMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Aug 01, 2025
Mucin 16-Directed Therapy in Pediatric Sarcomas: Case Evidence of Ubamatamab Efficacy in Epithelioid Sarcoma and Its Implications for Other Sarcoma Subtypes.

Denise M Connolly, Gabriel Revon-Rivière, Rose Chami

|Jun 13, 2025
Accelerating Drug Development for Neuroblastoma: Consensus Statement From the Third Neuroblastoma Drug Development Strategy Forum.

Steven G DuBois, Lucas Moreno, John Anderson

|Jun 12, 2025
Assessing the Impact of u-link.care: Implementation of a Pediatric Cancer Clinical Trials Finder Website to Improve Healthcare Provider Knowledge and Identify Barriers to Enrollment.

Cielle Stapleton, Ashley Doka, Lucie Pecheux

|May 02, 2025
A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors.

Filemon S Dela Cruz, Elizabeth Fox, Steven G DuBois

|Apr 23, 2025
Venetoclax Alone or in Combination With Chemotherapy in Paediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Myeloid Leukaemia.

Seth E Karol, Seong L Khaw, C Michel Zwaan

|Feb 14, 2025
The anti-GD2 monoclonal antibody naxitamab plus GM-CSF for relapsed or refractory high-risk neuroblastoma: a phase 2 clinical trial.

Jaume Mora, Godfrey C F Chan, Daniel A Morgenstern

Pageof 6

Frequent Collaborators

8 joint publications

Sarah Cohen-Gogo

5 joint publications

Uri Tabori

5 joint publications

Rebecca J Deyell

5 joint publications

Meredith S Irwin